4//SEC Filing
MCGRATH JOHN 4
Accession 0001209191-17-049449
CIK 0001604464other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:36 PM ET
Size
12.3 KB
Accession
0001209191-17-049449
Insider Transaction Report
Form 4
MCGRATH JOHN
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-08-16$14.39/sh−2,100$30,219→ 120,957 total - Exercise/Conversion
Common Stock
2017-08-15+7,697→ 125,157 total - Sale
Common Stock
2017-08-15$14.23/sh−2,100$29,883→ 123,057 total - Exercise/Conversion
Restricted Stock Units
2017-08-15−7,697→ 12,829 total(indirect: See Footnote)→ Common Stock (7,697 underlying)
Footnotes (8)
- [F1]Shares issued upon settlement of vested restricted stock units ("RSUs").
- [F2]Transaction pursuant to Rule 10b5-1 Plan adopted July 6, 2016.
- [F3]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $14.20 to $14.275. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $14.05 to $14.60. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock or a cash settlement.
- [F6]The RSUs were granted with both (a) a liquidity event-based vesting condition and (b) a service-based vesting condition, both of which conditions must be satisfied in order for the RSUs to vest. The liquidity event-based condition was satisfied upon the closing of the Issuer's initial public offering (the "IPO"). The shares that vested on the closing date of the IPO, and the shares that vested thereafter through May 15, 2015, were settled on May 15, 2015. The service-based vesting condition provides that 25% of the total number of shares on January 6, 2015 and 1/48th of the total number of shares monthly thereafter, subject to the holder's continuous service through each such date.
- [F7]The earlier of (i) December 12, 2020 or (ii) the recipient's termination date.
- [F8]The shares are held by the David B. Horowitz and John McGrath Jr. Revocable Living Trust dated 6/3/11, of which the Reporting Person is trustee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001205442
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:36 PM ET
- Size
- 12.3 KB